Innovative Health Initiative JU Call 11 · Leveraging Europe's Expertise to accelerate Cell Therapy for Type 1 Diabetes · Opportunity · GRANTIBASE · GRANTIBASE
Innovative Health Initiative JU Call 11 · Leveraging Europe's Expertise to accelerate Cell Therapy for Type 1 Diabetes
Horizon EuropeHorizon Europe€8.8m
Expected Impact:The action under this topic is expected to achieve the following impacts: • to support the widespread adoption of beta-cell therapy, ensuring long-term efficacy, accessibility, and integration into healthcare systems; • to accelerate the development of stem cell-based therapies thro…
Topics
Country:eu WideEligible:clinical Research ConsortiumEligible:healthcare ProviderEligible:research InstitutionEligible:UniversityFunding Size:unknownOpportunity Kind:project GrantOpportunity Type:grantSource:FTTiming:UnknownDigitalHealthManufacturingAIBiotechMaterialsSpaceInnovation General
Partner types
clinical_research_consortium, healthcare_provider, research_institution, university
